Factor VII Deficiency
Links shared publicly online about this topic
Factor VII: eMedicine Hematology
emedicine.medscape.com — “Overview: Blood coagulation is a series of reactions in which plasma zymogens are converted into active enzymes. The final event of these reactions is the formation of an insoluble fibrin clot. These coagulant reactions are regulated by ...” View full resource at emedicine.medscape.com
Most Recently Shared on June 2, 2010 at 8:29 pm By:
Julie Bohlen Health Executive and Active Health Library
Blood Factor VII is synthesized in the liver and secreted as a single-chain glycoprotein of 48 k. Learn more. http://bit.ly/9cV2H4
Recombinant Activated Factor VII in Severe Trauma | The NNT
thennt.com — “Recombinant Activated Factor VII in Severe Trauma | The NNT” View full resource at thennt.com
Most Recently Shared on August 25, 2011 at 6:41 pm By:
Colin Son Doctor, Medical Student, and Physician
Head bleeds though? RT @grahamwalker: Another NNT Review Up: Factor VII for Trauma. Sorry, doesn't appear to work http://t.co/wR8InLf
The Use of Activated Recombinant Factor VII in a Patient with Fulminant Hepatic Failure Requiring Placement of an Intracranial Pressure Monitor
theannals.com — “The Use of Activated Recombinant Factor VII in a Patient with Fulminant Hepatic Failure Requiring Placement of an Intracranial Pressure Monitor” View full resource at theannals.com
Most Recently Shared on October 29, 2011 at 2:50 pm By:
The Use of Activated Recombinant Factor VII in a Patient with Fulminant Hepatic Failure Requiring Placement of a... http://t.co/Anm4Y0Uy
Recombinant activated Factor VII not as effective as previously thought | HemOncToday
hemonctoday.com — “Although recombinant activated Factor VII reversed the effects of warfarin, it did not lead to improvements in bleeding model parameters, acc” View full resource at hemonctoday.com
Most Recently Shared on August 11, 2010 at 3:42 pm By:
HemOnc Today Oncology and Health News
Recombinant activated Factor VII not as effective as previously thought http://bit.ly/bRry6c
Federal investigators probing Army's using of blood-clotting drug Factor VII - baltimoresun.com
baltimoresun.com — “Federal investigators are exploring the Army's use of a controversial and expensive blood-clotting drug injected into wounded troops in Iraq and Afghanistan.” View full resource at baltimoresun.com
Most Recently Shared on May 17, 2010 at 4:27 am By:
Federal agents probing Army's use of Factor VII in Combat http://tinyurl.com/264vhcw
Federal investigators probing Army's using of blood-clotting drug Factor VII - OrlandoSentinel.com
orlandosentinel.com — “Federal investigators are exploring the Army's use of a controversial and expensive blood-clotting drug injected into wounded troops in Iraq and Afghanistan.” View full resource at orlandosentinel.com
Most Recently Shared on May 16, 2010 at 12:44 pm By:
HealthTrendster Health Executive
Federal agents probing Army's use of trauma drug: Federal criminal investigators are… http://goo.gl/fb/hGVNt
Unbound MEDLINE | Quality of Life After Severe Trauma: Results From the Global Trauma Trial With Recombinant Factor VII. PubMed Journal article
unboundmedicine.com — “Unbound MEDLINE/PubMed | Quality of Life After Severe Trauma: Results From the Global Trauma Trial With Recombinant Factor VII. PubMed Journal article. Search PubMed by keyword, journal, author or by EBM filters diagnosis, treatment, prognosis or etiology. Evidence-based medicine search filters.” View full resource at unboundmedicine.com
Most Recently Shared on March 13, 2011 at 3:50 pm By:
Pieter Kubben Doctor, Physician, and PhD
Quality of Life After Severe Trauma: Results From the Global Trauma Trial w/ Recomb. Factor VII http://bit.ly/gHnWbE (via @neurocirurgiabr)
Oncology Article | Hemorrhage
mdlinx.com — “Recombinant, activated factor VII for surgery in factor VII deficiency: a prospective evaluation -- the surgical STER” View full resource at mdlinx.com
Most Recently Shared on January 5, 2011 at 12:16 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Recombinant, activated factor VII for surgery in factor VII deficiency: a prospective evaluation – the... http://bit.ly/gOItuE #oncology
Cardiomyopathy, Hypertrophic on #MDlinx
mdlinx.com — “Cardiomyopathy, Hypertrophic on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on October 19, 2010 at 6:06 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Anticoagulation of a patient with hypertrophic cardiomyopathy and factor VII deficiency: Blood Coagulat... http://bit.ly/be2HSC #cardiology
Hemophilia drug can damage heart, study finds | Reuters
reuters.com — “BOSTON (Reuters) - Using high doses of Novo Nordisk's anti-clotting medicine to treat dangerous bleeding in non-hemophiliacs may raise the risk of heart attack or related complications, researchers said” View full resource at reuters.com
Most Recently Shared on November 3, 2010 at 9:22 pm By:
Hemophilia drug can damage heart, study finds http://dlvr.it/7zV10
Emergency Medicine Article | Trauma
mdlinx.com — “Recombinant Activated Factor VII Safety in Trauma Patients” View full resource at mdlinx.com
Most Recently Shared on May 26, 2011 at 10:26 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Recombinant Activated Factor VII Safety in Trauma Patients: Journal of Trauma http://bit.ly/mObN3M #ER
Emergency Med Medical News about Coagulation trauma
mdlinx.com — “Activated recombinant factor VII (rFVIIa)” View full resource at mdlinx.com
Most Recently Shared on March 12, 2010 at 8:24 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
#ER Activated recombinant factor VII (rFVIIa): Best Practice & Research - Clinical Anaesthesiology http://bit.ly/bQeDN3
Endocrinology Article | Hypercholesterolemia
mdlinx.com — “R353Q polymorphism in the factor VII gene and cardiovascular risk in Heterozygous Familial Hypercholesterolemia: a case-control study” View full resource at mdlinx.com
Most Recently Shared on April 12, 2011 at 7:17 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
R353Q polymorphism in the factor VII gene and cardiovascular risk in Heterozygous Familial Hypercholestero... http://bit.ly/eQ4YuD #endo
Pfizer Receives FDA Approval For Prefilled Dual-Chamber Syringe For Use In The Treatment Of Hemophilia A - QualityPoint Technologies
qualitypointtech.net — “Pfizer Inc.has announced that the U.S. Food and Drug Administration (FDA) has granted approval of the use of a Prefilled Dual-Chamber Syringe for administration of XYNTHA Antihemophilic Factor (Recombinant) Plasma/Albumin-Free to hemophilia A patients. XYNTHA is a recombinant factor VIII product indicated for both the control and prevention of bleeding episodes in patients with hemophilia A (congenital factor VIII deficiency or classic hemophilia) and for surgical prophylaxis in patients with he” View full resource at qualitypointtech.net
Most Recently Shared on August 10, 2010 at 11:57 am By:
Pfizer Receives FDA Approval For Prefilled Dual-Chamber Syringe For Use In The Treatment Of Hemophilia A: Pfizer I... http://bit.ly/bK0qIB
Factor XI Deficiency: eMedicine Hematology
emedicine.medscape.com — “Overview: Factor XI (FXI) deficiency is an autosomal disorder that may be associated with bleeding. Other terms for this disorder include plasma thromboplastin antecedent (PTA) deficiency, Rosenthal syndrome, and hemophilia C. Rosenthal first described this bleeding disorder ...” View full resource at emedicine.medscape.com
Most Recently Shared on June 2, 2010 at 9:25 pm By:
Factor XI (FXI) deficiency is an autosomal disorder that may be associated with bleeding. Learn more about factor XI. http://bit.ly/bQKYGS
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Julie Bohlen
Health content professional with MBA in heathcare management. Sharing quality health resources and news. On executive team at OrganizedWisdom.
-
Colin Son
A neurosurgical intern slowly coming to terms my life isn't more like Scrubs
-
The Annals
The Annals of Pharmacotherapy is a peer-reviewed medical journal advancing drug therapy by publishing evidence-based pharmacy research and clinical reviews.
Advertisement
